New York Life Investment Management’s ARS Pharmaceuticals SPRY Stock Holding History

New York Life Investment Management’s Portfolio SPRY Stock Details SPRY Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$1.38M	Buy
2022 Q3	$762K	Buy
2022 Q2	$563K	Buy